No association between serum adenosine deaminase activity and disease activity in Crohn's disease (Q50587883)

16 March 2018

title

No association between serum adenosine deaminase activity and disease activity in Crohn's disease (English)

1 reference

16 March 2018

author

Ali Gholamrezaei

series ordinal

2

1 reference

16 March 2018

author name string

Mahmoud Sajjadi

series ordinal

1

1 reference

16 March 2018

Nasser Ebrahimi Daryani

series ordinal

3

1 reference

16 March 2018

publication date

5 February 2015

1 reference

16 March 2018

Digestive Diseases and Sciences

published in

1 reference

16 March 2018

volume

60

1 reference

16 March 2018

issue

6

1 reference

16 March 2018

page(s)

1755-1760

1 reference

16 March 2018

Inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Diagnostics of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Laboratory markers in IBD: useful, magic, or unnecessary toys?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

A simple clinical colitis activity index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Does clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Crohnʼs disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Elevated adenosine deaminase levels in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Serum adenosine deaminase levels in pancreatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Fecal Markers: Calprotectin and Lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Myeloperoxidase and adenosine-deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Adenosine: an immune modulator of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3510-Y

Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis.

21 January 2018

1 reference

12 December 2020

Adenosine deaminase activity in patients with Crohn's disease: distinction between active and nonactive disease

1 reference

12 December 2020

Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings

1 reference

12 December 2020

Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI

1 reference

12 December 2020

Monitoring inflammatory bowel disease activity: Clinical activity is judged to be more relevant than endoscopic severity or biomarkers

1 reference

12 December 2020

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

1 reference

12 December 2020

Adenosine, an endogenous anti-inflammatory agent

1 reference

12 December 2020

Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level

1 reference

12 December 2020

Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern

1 reference

12 December 2020

Serum adenosine deaminase may predict disease activity in rheumatoid arthritis

1 reference

12 December 2020

Irritable Bowel Syndrome–Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation?

1 reference

12 December 2020

10.1007/S10620-014-3510-Y

Identifiers

DOI

1 reference

16 March 2018

1 reference

16 March 2018